Most trusted source for Tendering Opportunities and Business Intelligence since 2002
Country - Germany
Summary - First-In-Human, Dose Escalation, Phase I Study Of An Antibody-Based Immunotherapy In Patients With Solid Tumor (Kopie)
Deadline - Dec 04, 2024
GT reference number - 97813179
Product classification - Services provided by medical laboratories
Address - Germany
Contact details - 565656565
Tender notice no. - 76454545
GT Ref Id - 97813179
Document Type - Tender Notices
Description - Description: Conduct of a multicenter, first-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor (basket trial).local title:: First-in-human, dose escalation, phase I study of an antibody-based imm unotherapy in patients with solid tumor (Kopie)Contract Duration: : 4 YEARContract Type: : Servicelocal description: : Conduct of a multicenter, first-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor (basket trial). dispatch_date: 2024-11-15 00:00:00 lot_details: 1: First-in-human, dose escalation, phase I study of an antibody-based immunotherapy in patients with solid tumor (Kopie)
Gt Ref Id - 97813179
Deadline - Dec 04, 2024
Similar Tenders :
Why Us
3,00,000 +
Users
190 +
Countries Covered
5,00,000 +
Agencies Tracked
50,000 +
Notices Daily
90 Million +
Database